As of the latest Form 4 filed Apr 27, 2026.
What ClearSign Combustion Corporation insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 14 most recent filings for CLIR.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | 2026-04-23 | Silva Gil Todd Director | PPurchase | +1.00K | $5.25 | $5.25K | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-23 | Silva Gil Todd, Director | PPurchase | +1.00K | $5.32 | $5.32K | No | Form 4 ↗ |
| 2026-03-19 | 2026-03-17 | Silva Gil Todd Director | PPurchase | +2.00K | $4.20 | $8.40K | No | Form 4 ↗ |
| 2026-03-19 | 2026-03-16 | Silva Gil Todd, Director | PPurchase | +2.00K | $4.36 | $8.71K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Deller Colin James Chief Executive Officer | FTax | −105K | $0.56 | $59.0K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Deller Colin James, Chief Executive Officer | AAward | +210K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Hinds Brent Chief Financial Officer | FTax | −20.8K | $0.56 | $11.7K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Hinds Brent, Chief Financial Officer | AAward | +56.6K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-24 | 2026-02-22 | Hinds Brent Chief Financial Officer | FTax | −2.77K | $0.59 | $1.64K | No | Form 4 ↗ |
| 2026-02-24 | 2026-02-22 | Hinds Brent, Chief Financial Officer | MExercise | +7.55K | — | — | No | Form 4 ↗ |
| 2026-02-24 | 2026-02-20 | Hinds Brent, Chief Financial Officer | FTax | −3.41K | $0.59 | $2.03K | No | Form 4 ↗ |
| 2026-02-24 | 2026-02-20 | Hinds Brent, Chief Financial Officer | MExercise | +9.31K | — | — | No | Form 4 ↗ |
| 2026-02-04 | 2026-02-02 | Hinds Brent Chief Financial Officer | FTax | −3.71K | $0.60 | $2.22K | No | Form 4 ↗ |
| 2026-02-04 | 2026-02-02 | Hinds Brent, Chief Financial Officer | MExercise | +10.1K | — | — | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also CLIR’s full analysis or the market-wide insider trading feed. The tabs above jump to CLIR’s other SEC data.
Source: SEC Form 4 filings for CLIR, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.